The Wellness Company has secured nearly C$1.6 million in seed funding, giving the Toronto-based consumer healthtech startup fresh capital to
CNS trial activity remains broad and globally distributed, but GlobalData clinical trials data shows development is still concentrated in planned,
Human-centered artificial intelligence is now a widely stated principle in healthcare, but evidence for what it actually delivers in practice
Hospital at Home has moved beyond short-term pilots into a more stable, scalable care model. With a new five-year federal
Human-centered artificial intelligence is now a widely
The Wellness Company has secured nearly C$1.6 million in seed funding, giving the Toronto-based consumer healthtech startup fresh capital to
CNS trial activity remains broad and globally distributed, but GlobalData clinical trials data shows development is still concentrated in planned,
Human-centered artificial intelligence is now a widely stated principle in healthcare, but evidence for what it actually delivers in practice
Hospital at Home has moved beyond short-term pilots into a more stable, scalable care model. With a new five-year federal
Human-centered artificial intelligence is now a widely
Human-centered artificial intelligence is now a widely stated principle in healthcare, but
The debate over billing codes for AI-enabled clinical services has exposed a
Healthcare AI operations are moving from isolated experiments into the everyday work
Healthcare AI productivity will depend less on how many artificial intelligence tools
Healthcare organizations are investing heavily in artificial intelligence, with much of the
Healthcare consumers routinely face an experience that would seem unacceptable in almost
Twenty percent of healthcare providers have admittedly used unapproved artificial intelligence diagnostic
AI health prediction could help healthcare professionals identify future medical problems earlier
Healthcare agentic AI will not succeed simply because hospitals adopt more advanced
Generative AI guidance is coming from the U.S. Food and Drug Administration
The Scale of Adoption Behind This HIMSS AI Landscape APAC 2026 ReportGenerative
Why Cancer Data Makes AI Cancer Registrar Abstraction So ChallengingA Story That
What the FDA AI Medical Devices Patient Outcomes Study FoundThe Publication Gap
Healthcare AI Value Moves Into ProductionHealthcare AI Value Requires Clinical UtilityDiagnostics Demonstrate
Healthcare AI Accountability Enters ProductionHealthcare AI Accountability Requires ContextHealthcare-Specific AI Becomes a
How AI Rare Disease Diagnosis Tools Compressed a Diagnostic Timeline at Mayo
The Scale of AI Clinical Decision Support Trials ExposureWhy This Isn't a
What the Oracle Health AI Patient Portal Actually OffersThe Foundation Model Powering
The Evidence Base Behind AI GI Cancer Clinical ValueA New Phase Where
How the AI Dividend Healthcare Philips Index Measures Clinician ImpactThe Time Savings
